Cross-presentation, dendritic cell subsets, and the generation of immunity to cellular antigens
- PMID: 15233723
- DOI: 10.1111/j.0105-2896.2004.00142.x
Cross-presentation, dendritic cell subsets, and the generation of immunity to cellular antigens
Abstract
Cross-presentation involves the uptake and processing of exogenous antigens within the major histocompatibility complex (MHC) class I pathway. This process is primarily performed by dendritic cells (DCs), which are not a single cell type but may be divided into several distinct subsets. Those expressing CD8alpha together with CD205, found primarily in the T-cell areas of the spleen and lymph nodes, are the major subset responsible for cross-presenting cellular antigens. This ability is likely to be important for the generation of cytotoxic T-cell immunity to a variety of antigens, particularly those associated with viral infection, tumorigenesis, and DNA vaccination. At present, it is unclear whether the CD8alpha-expressing DC subset captures antigen directly from target cells or obtains it indirectly from intermediary DCs that traffic from peripheral sites. In this review, we examine the molecular basis for cross-presentation, discuss the role of DC subsets, and examine the contribution of this process to immunity, with some emphasis on DNA vaccination.
Similar articles
-
Anatomic location defines antigen presentation by dendritic cells to T cells in response to intravenous soluble antigens.Eur J Immunol. 2007 Jun;37(6):1453-62. doi: 10.1002/eji.200636544. Eur J Immunol. 2007. PMID: 17474148
-
Control of dendritic cell cross-presentation by the major histocompatibility complex class I cytoplasmic domain.Nat Immunol. 2003 Nov;4(11):1065-73. doi: 10.1038/ni989. Epub 2003 Oct 19. Nat Immunol. 2003. PMID: 14566337
-
Cross-presentation: underlying mechanisms and role in immune surveillance.Immunol Rev. 2005 Oct;207:166-83. doi: 10.1111/j.0105-2896.2005.00301.x. Immunol Rev. 2005. PMID: 16181335 Review.
-
The delivery of an antigen from the endocytic compartment into the cytosol for cross-presentation is restricted to early immature dendritic cells.Immunology. 2006 Jan;117(1):97-107. doi: 10.1111/j.1365-2567.2005.02270.x. Immunology. 2006. PMID: 16423045 Free PMC article.
-
A novel pathway of antigen presentation by dendritic and endothelial cells: Implications for allorecognition and infectious diseases.Transplantation. 2006 Jul 15;82(1 Suppl):S15-8. doi: 10.1097/01.tp.0000231347.06149.ca. Transplantation. 2006. PMID: 16829787 Review.
Cited by
-
Classification of current anticancer immunotherapies.Oncotarget. 2014 Dec 30;5(24):12472-508. doi: 10.18632/oncotarget.2998. Oncotarget. 2014. PMID: 25537519 Free PMC article. Review.
-
Trial watch: DNA vaccines for cancer therapy.Oncoimmunology. 2013 Apr 1;2(4):e23803. doi: 10.4161/onci.23803. Oncoimmunology. 2013. PMID: 23734328 Free PMC article.
-
Intradermal delivery of DNA encoding HCV NS3 and perforin elicits robust cell-mediated immunity in mice and pigs.Gene Ther. 2016 Jan;23(1):26-37. doi: 10.1038/gt.2015.86. Epub 2015 Oct 1. Gene Ther. 2016. PMID: 26262584
-
Early establishment of diverse T cell receptor profiles for influenza-specific CD8(+)CD62L(hi) memory T cells.Proc Natl Acad Sci U S A. 2006 Jun 13;103(24):9184-9. doi: 10.1073/pnas.0603289103. Epub 2006 Jun 5. Proc Natl Acad Sci U S A. 2006. PMID: 16754852 Free PMC article.
-
Proteasomes in immune cells: more than peptide producers?Nat Rev Immunol. 2010 Jan;10(1):73-8. doi: 10.1038/nri2687. Epub 2009 Dec 11. Nat Rev Immunol. 2010. PMID: 20010787 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials